SPIA
PROF

Steward Partners Investment Advisory’s Profound Medical PROF Stock Holding History

Steward Partners Investment Advisory’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$3K – 3286
2021
Q3 		$3K Hold
200
– – ﹤0.01% 2939
2021
Q2 		$3K Hold
200
– – ﹤0.01% 6791
2021
Q1 		$4.01K Hold
200
– – ﹤0.01% 3068
2020
Q4 		$4K Hold
200
– – ﹤0.01% 2580
2020
Q3 		$4K Hold
200
– – ﹤0.01% 2443
2020
Q2 		$3K Buy
+200
New +$2.52K ﹤0.01% 2406

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Steward Partners Investment Advisory's PROF Position: Q4 2021 in Review

Steward Partners Investment Advisory sold out of Profound Medical (PROF) in Q4 2021, closing a stake of 200 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in PROF in Q2 2020 and held it in 6 quarters. The position peaked at $4.01K in Q1 2021. 46 funds tracked by Wall St. Rank hold PROF as of Q4 2021.

  • Steward Partners Investment Advisory reported no remaining Profound Medical position as of Q4 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 200 Profound Medical shares in Q4 2021, an estimated $3K.
  • Steward Partners Investment Advisory first reported a position in Profound Medical in Q2 2020 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Profound Medical position peaked at $4.01K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Profound Medical as of Q4 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2021, filed 8 Feb 2022.